Schistosomiasis in a Scottish school group after freshwater swimming in Uganda:the need to raise awareness by Currie, Sandra L. et al.
                                                              
University of Dundee
Schistosomiasis in a Scottish school group after freshwater swimming in Uganda








Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Currie, S. L., Denvir, L., Mooka, B., Perrow, K., & Alexander, C. L. (2018). Schistosomiasis in a Scottish school
group after freshwater swimming in Uganda: the need to raise awareness. BMJ Case Reports, 5(10), 1-5.
[e005166]. https://doi.org/10.1099/jmmcr.0.005166
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 05. Apr. 2019
Downloaded from www.microbiologyresearch.org by
IP:  134.36.139.90
On: Tue, 04 Dec 2018 14:29:40
Schistosomiasis in a Scottish school group after freshwater
swimming in Uganda: the need to raise awareness
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Abstract
Introduction. Schistosomiasis, a travel-related trematode infection, can cause a range of symptoms with potentially life-
threatening complications. In this report, we describe an outbreak of schistosomiasis in a Scottish school group that had
travelled to Uganda. We discuss the requirement for robust and accurate pre-travel advice, and the importance of raising
awareness in travellers, particularly due to the asymptomatic nature of the disease. In addition, we highlight the need to
submit a serum sample for laboratory testing on return from endemic regions where freshwater exposure has occurred.
Case presentation. A Scottish school group consisting of 19 individuals visited Uganda during July 2016 with one positive
symptomatic case identified on return to the UK. As three of the individuals were not Scottish residents, their data were
excluded from this report. Freshwater exposure was noted from taking part in activities which included swimming in the
Nile. The Scottish Parasite Diagnostic and Reference Laboratory performed serology testing using sera from 16 Scottish
residents to detect IgG towards Schistosoma egg antigens. Thirteen were positive despite only one case being symptomatic.
Conclusion. The high positivity rate raised several issues. These included the lack of a robust risk assessment by the travel
company organizing the trip, the lack of awareness of schistosomiasis by some individuals, the lack of appropriate and
accurate pre-travel advice, and the asymptomatic nature of the infection. This report provides supportive evidence to
strengthen the need for improvements to prevent largely asymptomatic cases being missed in future.
INTRODUCTION
Schistosoma species are trematode parasites responsible for
causing schistosomiasis, identified as a neglected tropical
disease by the World Health Organisation [1]. Also known
as bilharzia, there are around 230million people infected
worldwide [2, 3]. There are five main species that infect
humans, namely Schistosoma mansoni, S. haematobium,
S. japonicum, S. intercalatum and S. mekongi. The life cycle
involves the release of free-swimming cercariae from
infected snails in freshwater which penetrate human skin.
This is most likely to occur during water-based activities,
including swimming, water sports and bathing. Endemic
areas include Africa, South East Asia, South America and
the Middle East [3].
In the UK, tourism to Uganda has increased five-fold in a
decade, with 11% of visitors to the country travelling from
the UK in 2013 [4]. Travel to endemic areas is becoming
increasingly accessible, and is likely to rise as Scotland
continues to have strong links with East Africa. Notably,
partnerships through volunteer schemes with Uganda and
the Scotland–Malawi partnership promote the development
and maintenance of connections between schools, commu-
nity groups and individuals.
In Scotland, schistosomiasis is the most frequently reported
parasitic disease in travellers with over 8000 cases occurring
during 2001–2015 and a 25% positivity rate [5, 6]. Serology
testing is advised in those who have been to an endemic
region and who have had freshwater exposure. A blood
sample is requested at least 8 weeks following the last expo-
sure date, or sooner should symptoms occur. Infection is
largely asymptomatic in Scottish travellers, and therefore
the number of positive cases in Scotland is likely to be
underestimated [5, 6]. Although many travellers are asymp-
tomatic, initially, patients may experience a rash or skin irri-
tation known as swimmers’ itch. This is caused by
penetration of the skin by the cercariae. Katayama syn-
drome may occur after 1–2months with symptoms
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including fever, chills, cough, urticaria, arthralgias, lymph-
adenopathy, splenomegaly and abdominal pain. If left
untreated, schistosomiasis can lead to potentially life-
threatening conditions including advanced hepatic fibrosis
disease, portal hypertension, squamous-cell carcinoma of
the bladder and central nervous system lesions [7]. In addi-
tion, host response to eggs in the genital tract can result in
genital lesions and have the potential to cause infertility or
adverse pregnancy outcomes. Administration of the drug
praziquantel, which kills adult worms, to halt egg produc-
tion is essential to alleviate symptoms and to prevent long-
term disease. Treatment is dependent on a positive serology
finding. However, if travellers are not aware of the disease,
and are infected but asymptomatic, they will not receive
testing and therefore will go untreated.
This report describes the important outcomes of laboratory
testing that detected Schistosoma antibodies in a Scottish
school group. The group comprised 17 students and two
teachers who had visited a known endemic region, Uganda,
during July 2016. Three of the group resided outside Scot-
land and are not included in this report.
CASE REPORT
Investigations
Initially, one patient with gastrointestinal symptoms pre-
sented to their general practitioner (GP) and was tested by
the Scottish Parasite Diagnostic and Reference Laboratory
(SPDRL) for Schistosoma antibodies 3 months after return-
ing to the UK. Testing was requested as the individual had
been to an endemic region and had experienced freshwater
contact. The serum sample from this symptomatic traveller
was found to be positive for Schistosoma IgG. A further five
positive cases were identified 7 months after returning
home. All five cases were asymptomatic and had attended
their local GP to request testing on their own initiative. All
noted recent travel to Uganda and contact with freshwater.
Subsequently, the local Health Protection Team (HPT) was
notified. The number of cases and the age of the patients
suggested a school trip. Through contact with the local edu-
cation department, the HPT identified a school which had
visited Uganda in July 2016, comprising 19 individuals in
total. Three were resident outside Scottland and were con-
tacted by the local HPT to recommend testing in their local
area. This left 16 members of the group, inclusive of the five
cases initially identified.
Diagnosis
All of the 16 Scottish participants submitted 5–10 ml clotted
blood for Schistosoma IgG testing by the SPDRL after the
initial cluster of five positive cases were identified.
Briefly, 100 µl of patient sample was diluted in wash buffer
and added to the well of a 96-well plate coated with Schisto-
soma egg antigens (DRG Diagnostics). Samples were incu-
bated for 1 h at 37

C before being washed three times in
wash buffer. One hundred microlitres of horseradish perox-
idase-labelled Protein A conjugate was added to each well
and incubated at room temperature for 30 min in the dark.
Wells were washed a further three times in wash buffer
before the addition of 100 µl tetramethylbenzidine substrate
to each well. After incubating for 15 min in the dark at
room temperature, 100 µl of stop solution was added to
each well before the optical density of each well was read on
an ELISA microwell plate reader at a wavelength of 450 nm
(Flow Laboratories). The sensitivity and specificity of the
assay are given by the manufacturer as 87 and 95%, respec-
tively. Following detection of Schistosoma IgG, faeces and
urine samples were submitted for examination of ova using
light microscopy wet preparations.
As the majority of Scottish travellers infected with Schisto-
soma species are likely to be asymptomatic, it was advised
that all members of the group needed to be tested regardless
of the lack of symptoms to ensure appropriate drug therapy
was administered to those who tested positive. After notify-
ing individuals to attend their local GPs to have blood sam-
ples taken, a total of 13 positive cases were identified
(Table 1). Twelve of the 13 positive cases submitted stool
and urine samples, which were negative for Schistosoma
ova. All involved were identified within 1 week of the initial
notification, and before complications arose. Information
provided by the SPDRL was disseminated to group mem-
bers through a contact with the school.
Treatment
Infectious diseases specialists were contacted to assess and
treat the individuals. Due to parent concern and the high
positivity rate in this group, a one-time additional clinic for
positive patients was arranged. Praziquantel treatment was
offered to and accepted by all positive cases. The drug was
given on a weight-based dosing schedule. Each patient’s
weight was therefore collected by the HPT through the
school via email prior to the clinic to ensure that a sufficient
amount of this drug was available.
Table 1. Summary of schistosomiasis cases including water exposure and laboratory findings
Total number on the trip 19 (2 staff and 17 pupils)
Total number of Scottish residents 16 (5 males; 11 females)
Total number of individuals tested by ELISA 16
Total number of ELISA-positive individuals who had swum in the river 13 (5 males; 8 females)
Total number of ELISA-negative individuals 3 (all female; one had swum)
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DISCUSSION
This report highlights several important findings. Firstly,
the group was not aware of the risk posed by freshwater
swimming. Secondly, they were not aware that the Scottish
diagnostic criteria was to test those who have had water
exposure and travel to an endemic region. Thirdly, only one
patient was symptomatic, which led to the outbreak being
identified, despite a large percentage of the group being
infected (81%, 13/16). Two of the three negative patients
had not taken part in the freshwater swimming, which was
thought to be the source of infection.
Testing had been encouraged through the school before
HPT involvement, due to the first positive symptomatic
case. The HPT contacted the group through the lead teacher
who provided names and contact details, allowing the HPT
to remind those who had not been tested to book an
appointment with their GP. The lead teacher provided addi-
tional information on schistosomiasis to the group from
various sources including: (a) NHS Choices website (http://
www.nhs.uk/pages/home.aspx), (b) Fit-for-Travel website
(http://www.fitfortravel.nhs.uk/home.aspx), (c) email and
(d) a private Facebook group.
The purpose of further investigation by the HPT was to
encourage testing in the affected school group in order to
arrange treatment to prevent more serious long-term com-
plications occurring in the future. This was achieved
through communications with the group leader who sup-
plied contact information for those in the group, leading to
the identification of further cases. The lead teacher also
passed on information provided by the HPT on schistoso-
miasis to group members.
Schistosomiasis has been identified in at least 74 countries,
and has also been identified in those who have travelled to
regions not deemed to be endemic. One example was the
report describing S. haematobium/S. bovis hybrid in travel-
lers returning from Corsica, France, in 2014 [8]. In another
example, 23, 15 and 10% of Scottish travellers returning
from Europe, North America, and Australia and New Zea-
land, respectively, between 2001 and 2015 were Schisto-
soma-positive [5]. Links between Scotland and Africa are
particularly evident, and where country-specific data were
available, 40% of travellers to Uganda tested positive for
schistosomiasis upon their return [5]. Similarly, travel to
Uganda accounted for 24.9% of new cases of schistosomia-
sis identified in Scotland in 2005–2009 [9].
The data within this investigation mirror a report of a previ-
ous outbreak in a Scottish school group, which described a
group of travellers to Malawi [10]. In this group, 13/21
(62%) were found to be positive for schistosomiasis, and
only two patients were symptomatic. In the 6 years since
this report was published, schistosomiasis continues to be
documented in Scottish school groups returning from
abroad and has recently been reporting in a school group
from Denmark [5, 11]. Advice to schools was first published
in 2015 and is available online via the Health Protection
Scotland, TRAVAX and Fit-for-Travel websites [12]. In
addition, after the outbreak in this report, the Scottish Gov-
ernment wrote to schools via the local education authorities
to reinforce previous guidance, highlight the risks posed by
schistosomiasis and provide links for further advice. The let-
ter also highlighted that an individual travel health risk
assessment must be carried out by a qualified health profes-
sional for each person travelling.
This report adds further evidence to support the need to
raise awareness of schistosomiasis in returning travellers. In
June 2016, the Scottish Schistosomiasis National Advice,
Investigation and Liaison (SNAIL) group was launched in
response to these outbreaks, and other cases across Scot-
land. The aims of the SNAIL group include raising aware-
ness of schistosomiasis, particularly amongst higher risk
groups [6].
This investigation identified that a robust risk assessment
was lacking pre-travel. The school group did not appear to
receive information about schistosomiasis from any source
prior to travel, including exposure risk in freshwater, and
the recommendation for testing after return to the UK.
Information has now been disseminated by the Scottish
Government for the attention of schools intending travel to
at-risk countries. However, while this method will be of use
to school groups, it will not capture university groups or
volunteer organizations undertaking similar trips. Similarly,
around 90% of travellers to Uganda visit in groups of fewer
than four [4] and care should be taken to include smaller
groups or lone travellers when developing guidance.
One possible method of targeting travellers is via GPs or
private travel clinics used by individuals prior to travelling
to receive immunizations/malaria prophylaxis. These would
be useful platforms to provide information to those at risk.
Although infection risk by country is available on the
TRAVAX and Fit-for-Travel websites, the group described
in this report remained unaware of the risk until the first
member of the group became ill. An analysis of European
data found 486/1465 (33%) cases of imported schistosomia-
sis from 1997 to 2010 in travellers to endemic areas. Of
these travellers, only 18% received pre-travel advice [13].
This finding is supported by a study which analysed data
from 333 confirmed and probable cases of schistosomiasis
in Europe from 1999 to 2001 and found that of 147 patients
who provided additional data, only 40% (n=59) received
pre-travel advice on schistosomiasis [14]. In one Scottish
Health Board, out of 77 patients presenting to an Infectious
and Communicable Diseases Centre during 2011–2013 with
travel-related disease, 21 (27.3%) had not received a pre-
travel consultation [15].
In the outbreak reported here, the only reason cases were
identified was due to the one symptomatic case. Enquiring
about fellow travellers at the time of diagnosis or treatment
could potentially capture other positive cases. The SNAIL
group has established enhanced surveillance of schistosomi-
asis in Scotland since May 2016 which will permit much
Currie et al., JMM Case Reports 2018;5
Downloaded from www.microbiologyresearch.org by
IP:  134.36.139.90
On: Tue, 04 Dec 2018 14:29:40
more in-depth information on every case to be gathered.
This will greatly help to make evidence-based improve-
ments to pre- and post-travel advice.
The limitation of this study is that it represents an individ-
ual school on a single trip to one country. Therefore, the
results described in this report do not necessarily reflect
what happens to other school groups heading to endemic
regions as the information provided prior to travelling
varies depending on, for example, travel company, pre-
travel advice offered and previous experiences by
individual schools. Nevertheless, this study highlights that
outbreaks are still occurring and that despite comprehen-
sive pre-travel advice being readily available online it is
not always being provided to the pupils or their parents,
which is likely to result in affected individuals failing to
receive treatment.
Testing on return is advised at least 8 weeks after the last
exposure to freshwater, or sooner if symptoms occur. This
allows the adult worms time to mature, to mate and the
female to lay eggs. The test detects IgG towards egg antigens
and cannot differentiate between a current or previous
infection. Although Schistosoma antibodies can last for sev-
eral years after infection [16], it can be assumed that in trav-
elling school groups with limited past exposures, for
example only one visit to an endemic region, a positive
serology finding is likely to represent a recent infection and
hence treatment is advised. Further studies are on-going at
the SPDRL to explore alternative testing options that can be
used to determine whether infections are current and can be
used to determine treatment success.
Serology testing cannot be used to distinguish between
species. To do this, microscopy detection of ova in stools
and urine is used to examine the distinct differences in
egg morphology. In this outbreak, 12/13 positive individu-
als submitted samples for microscopy, and all were nega-
tive. This is supported by data from another recent report
of schistosomiasis in a Danish school group where 13
serology-positive cases had no ova identified from their
urine and stool samples [11]. Microscopy to detect Schisto-
soma ova lacks sensitivity, and parasite eggs may become
trapped in the lipid layer during the concentration process
and be discarded. In addition, returning travellers are
likely to have a low parasite burden due to limited fresh-
water exposure, reducing the chances of finding ova in
faeces or urine. This results in cases often being serology-
positive but microscopy-negative. Treatment is recom-
mended for all serology-positive cases, regardless of their
microscopy result.
Variations between Scottish NHS boards exist regarding the
timing of sampling, follow-up testing and treatment proto-
cols. The SNAIL group aims to address these areas to
improve future patient management. To prevent similar sit-
uations from occurring in future, it is crucial to raise aware-
ness of schistosomiasis. It is essential to inform all travellers,
not only school groups, of the risks involved before travel
and that testing is encouraged on return should they be
exposed to freshwater in endemic regions.
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